In conclusion, in the hitherto largest study of TERT promoter mutations in conventional CS, we observed that TERT promoter mutation was a negative prognostic marker, with a clear, significant correlation to high tumor grade, metastatic disease, and mortality. The gene discussed is TERT; the disease is metastatic neoplasm.